Master Alliance Provisions Guide (MAPGuide)

European Commission – CureVac, COVID-19 Vaccine Advance Purchase Agreement

  • Business model | Payment Structures

<p><span style=”textdecoration: underline;”><b>I.17 Payment Obligationsb>span>p>
<p><span style=”fontweight: 400;”><strong>I.17.1. Upfront paymentstrongspan>p>
<p><span style=”fontweight: 400;”>(a) In order to derisk the necessary investments of the contractor to increase the speed of vaccine research and development and clinical trials and the preparation of the atscale production capacity along the entire production value chain in the EU required for a rapid deployment of the millions of doses of the Product according to the terms of this APA, and in full understanding of the uncertainties associated with the aforementioned process, subject to EU marketing authorisation or temporary national authorisation (as the case may be), the Commission, acting on behalf and in the name of the participating Member States, and the participating Member States themselves shall contribute to financing the relevant costs in the form of an upfront payment on the total Product Price of the Initial European Doses (thespan><b><i>upfront paymenti>b><span style=”fontweight: 400;”>”) as set forth in this Article I.17.1 as well as in the form of the second upfront payment as set forth in Article I.17.2 and, as the case may arise, in the form of the Additional Doses upfront payment as set forth in this Article I.17.2span>p>
<p><span style=”fontweight: 400;”>(b) The upfront payment is EUR [Redacted Content] total (which will equal an upfront payment of EUR [Redacted Content].span>p>
<p><span style=”fontweight: 400;”>(c) Within [Redacted Content] calendar days following entry into force of the APA, the contractor shall send to the Commission a payment request for the payment of the upfront payment in accordance with Article II.15 belowspan>p>
<p><span style=”fontweight: 400;”>(d) The Commission, acting on behalf and in the name of the participating Member States, shall pay the upfront payment within [Redacted Content] calendar days after receipt of a payment request from the contractor in accordance with Article I.17.1(c) abovespan>p>
<p><span style=”fontweight: 400;”><strong>I.17.2. Payments under Vaccine Order Formsstrongspan>p>
<p><span style=”fontweight: 400;”>Pursuant to this Article I.17.2 and in accordance with their respective Vaccine Order Forms, the participating Member States shall make further payments to the contractor as followsspan>p>
<p><span style=”fontweight: 400;”>(a) With respect to the Initial European Doses, each participating Member State shall make a further upfront payment to the contractor in the amount of EUR [Redacted Content] for the volumes of the Product allocated to it pursuant to Articles I.8.1 and I.8.2 (thespan><b><i>second upfront paymenti>b><span style=”fontweight: 400;”>”). The second upfront payment (plus valueadded taxes, if any) shall be paid by the participating Member State within [Redacted Content] calendar days after notification by the contractor that the interim data package has been submitted to the EMA for the purpose of obtaining EU marketing authorisation for the Product, but no sooner than [Redacted Content] calendar days after receipt of a corresponding payment request from the contractor in accordance with Article II.15 belowspan>p>
<p><span style=”fontweight: 400;”>(b) With respect to the Additional European Doses, and assuming that the Commission has formally notified the contractor that a participating Member State wishes to acquire Additional European Doses in accordance with Article I.8.3, each such participating Member State shall make an upfront payment to the contractor in the amount of [Redacted Content] % of the Purchase Price per dose for the volumes of the Product allocated to it pursuant to Article I.8.3 (thespan><b><i>Additional Doses upfront paymenti>b><span style=”fontweight: 400;”>”). Such Additional Doses upfront payment (plus valueadded taxes, if any) shall be paid by the participating Member State within [Redacted Content] calendar days after conclusion of the relevant Vaccine Order Form (or, if a participating Member State refuses to conclude the relevant Vaccine Order Form, [Redacted Content] calendar days after the contractor&#8217;s explicit request to sign the relevant Vaccine Order Form), but no sooner than [Redacted Content] calendar days after receipt of a corresponding payment request from the contractor in accordance with Article II.15 belowspan>p>
<p><span style=”fontweight: 400;”>(c) Each participating Member State shall pay the balance (plus ancillary expenses (as defined in Article I.16.3) due on the Product Price for the volumes of the Product allocated to it pursuant to Articles I.8.1 through I.8.3 within [Redacted Content] calendar days of each delivery (or offer to deliver if the participating Member State illegitimately refuses acceptance of delivery), but no sooner than [Redacted Content] calendar days after receipt of a corresponding invoice from the contractor in accordance with Article II.15 below. The balance due will be calculated on the basis of the relevant Product Price of the delivered (or offered to deliver, as the case may be) Products as set out in Article I.16.1 above and under deduction of any upfront payment, second upfront payment and/or Additional Doses upfront payment already received by the contractor for the relevant volumes of the Product delivered (or offered to deliver, as the case may be). span>p>
<p><strong>I.17.3. Utilisation of the upfront payment and the second upfront payment strong>p>
<p><span style=”fontweight: 400;”>The contractor intends to use the upfront payment and the second upfront payment as span><span style=”fontweight: 400;”>further specified in Annex VII.span>p>
<p><span style=”textdecoration: underline;”><b>II.12 Reduction in Priceb>span>p>
<p><span style=”fontweight: 400;”><strong>II.12.1. Quality standardsstrongspan>p>
<p><span style=”fontweight: 400;”>If the contractor fails to deliver the Product in accordance with the APA, the participating Member State in question may reduce or recover payments in accordance with Article I.14.4span>p>
<p><strong>II.12.2. Procedure strong>p>
<p><span style=”fontweight: 400;”>The participating Member State in question must formally notify the contractor of its intention to reduce payment and the corresponding calculated amountspan>p>
<p><span style=”fontweight: 400;”>The contractor has 30 days following the date of receipt to submit observations. Failing that, the decision becomes enforceable the day after the time limit for submitting observations has elapsedspan>p>
<p><span style=”fontweight: 400;”>If the contractor submits observations, the participating Member State in question, taking into account the relevant observations, must notify the contractorspan>p>
<p><span style=”fontweight: 400;”>(a) of the withdrawal of its intention to reduce payment; or span>p>
<p><span style=”fontweight: 400;”>(b) of its final decision to reduce payment and the corresponding amountspan>p>